# A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body

> **NCT06166992** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 1291583
- **DRUG:** [14C]-BI 1291583

## Key facts

- **NCT ID:** NCT06166992
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-12
- **Primary completion:** 2024-02-07
- **Final completion:** 2024-02-07
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06166992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06166992, "A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06166992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*